Featured Webinars

41. Evolution Of Transparency Policies 6/3/2020

    In recent years, many sponsors have established or expanded their clinical trial transparency commitments. TrialScope speaks with two sponsors to find out how their organizations’ transparency commitment and policies have evolved. Watch the short video.

42. Outsourcing Clinical Trial Disclosure Management 6/3/2020

    Deciding to outsource clinical trial disclosure management is a sponsor’s first step. Deciding what processes to outsource is the next step. Two study sponsors discuss with TrialScope what they outsource and why. Watch the short video.

43. Why Disclosure As A Service? 6/3/2020

    Two clinical trial sponsors – one larger pharmaceutical company and one smaller biotech – share with TrialScope what their main reasons were for initially considering Disclosure as a Service. Watch the short video.

44. Sponsors' Advice On Disclosure As A Service 6/3/2020

    Representatives from Teva and Lung Biotechnology share their insights for other sponsors considering Disclosure as a Service. Watch the short video now.

45. How Sponsors Turn Disclosure As A Service Into A Strategic Advantage 5/18/2020

    In this panel discussion, Teva and Lung Biotechnology disclosure experts discuss why they opted for disclosure as a service. They will detail how it helps them safeguard regulatory compliance and mitigate risk.

46. PLS Perspectives: Sponsor, Author & Regulatory Viewpoints 2/24/2020

    In this informative webinar, Jazz Pharmaceuticals will provide tips on launching a PLS program. A medical writer from ClaritiDox will give an overview of PLS best practices. And TrialScope’s chief strategy officer will share – and analyze – results from TrialScope’s recent PLS survey.

47. Disclosure & Transparency Trends Webinar 1/15/2020

    Hear results from TrialScope’s 2019 Global Clinical Trial Disclosure & Transparency Benchmark Survey, highlights from our Plain Language Summaries Survey, and predictions for 2020.

48. Trends In Clinical Transparency Policies 1/15/2020

    More and more sponsors are making their clinical trial transparency policy publicly available, says TrialScope Chief Strategy Officer Thomas Wicks. Hear additional disclosure and transparency trends.

49. Importance And Requirements Of Study Results Posting 1/15/2020

    In addition to laws requiring disclosure of clinical trial results, the public also demands this information. TrialScope Chief Strategy Officer Thomas Wicks explains why sponsors should share study results.

50. Reporting To ClinicalTrials.gov: Reflections And Challenges 11/7/2019

    Who can reflect better on this topic than Dr. Deborah Zarin, former director of ClinicalTrials.gov? Dr. Zarin, now with the MRCT Center, shared her experiences and advice at the recent EXTRA: TrialScope Transparency Experience.